No profile data available.
Pelthos Therapeutics Inc. (PTHS) is a listed company, based in Durham, United States, with about 92 full-time employees.
It reported revenue of $0 for fiscal year 2024, and net income of -$7.96 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $7.41 million. Its market capitalization was $78.48 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
, a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.
Pelthos Therapeutics reported $0 in revenue for fiscal year 2024. In Q3 2025 revenue was $7.41 million.
$78.48 million as of October 9, 2026.